Navigation Links
Waismann Method Medical Director Cautions of Increasing Numbers of Opioid Addicts
Date:7/5/2011

BEVERLY HILLS, Calif., July 5, 2011 /PRNewswire/ -- Dr. Michael Lowenstein, co-medical director of The Waismann Method, an advanced procedure for rapid opiate detoxification under deep sedation, is expressing grave concern over the implications of a new report that outlines the alarming rise in number of individuals seeking treatment for opioid dependence, for example OxyContin addiction.

The new national analysis from the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) reports that admissions for opiate use, mostly as a result of prescription painkillers like Vicodin and OxyContin, showed the most staggering increase compared to other rehab admissions, such as alcohol and marijuana. The report stated prescription drugs were to blame for 33 percent of opiate rehab admissions in 2009, up from 8 percent in 1999 – an increase of 25 percent.

"It's alarming to see such a sharp rise in numbers of individuals seeking treatment for prescription drug addiction," said Dr. Lowenstein. "In the past decade, prescription opioids have become more common as a way to treat pain, and now we're seeing a backlash of patients struggling with addiction because the drugs were over-prescribed, improperly monitored, or abused by the user.  The U.S. population needs to be aware of the dangers and risks involved in taking prescription painkillers, and seek help for themselves or family members who may be in need of treatment or detoxification."

It is worth noting that not all substance treatment admissions increased during the study period.  The new SAMHSA report concluded that cocaine-related admissions between 1999 and 2009 actually decreased from 14 percent to 9 percent. The report also identified that five substance categories were responsible for 96 percent of the nearly 2 million admissions that occurred in 2009.  (The report only analyzed data for individuals 12 years and older.) The five substance groups include:

  • Alcohol (42 percent)
  • Opiates (21 percent)
  • Marijuana (18 percent)
  • Cocaine (9 percent)
  • Methamphetamines/amphetamines (6 percent)

In addition to being the co-medical director of the Waismann Method, Dr. Lowenstein is a pain specialist with expertise in multi-disciplinary pain management. He has more than 14 years experience in treating opiate dependency, and has been a pain specialist for more than 20 years.

The Waismann Method is a pioneering medical opiate detoxification procedure that is safe, humane and effective, and provides an alternative option for treatment of prescription painkiller dependency. The majority of opioid detoxification treatments center on facing and experiencing symptoms of withdrawal, whereas the Waismann Method patients experience minimal conscious withdrawal during treatment. A recent Waismann Method poll showed 35 percent of those facing treatment for opioids listed "fear of withdrawals" as the biggest challenge in overcoming their addiction.

For more information about the Waismann Method please visit Opiates.com.  For interviews contact Natalie Terashima at 858-922-3017 or send an email to natalie@rkpr.net.


'/>"/>
SOURCE Waismann Method
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Waismann Method Offers Safe and Alternative Treatment for Dependency to Ambien
2. The Waismann Method Reflects on 2009: The Year of the Prescription Painkiller
3. Waismann Method Supports National Take-Back Initiative
4. Waismann Method Extends Aid in an Effort to Make Treatment More Widely Available
5. Endoscopy Identified as Safe and Effective Method in Treating Common Complication of Gastric Bypass Surgery
6. Siemens Preclinical Imaging System Helps The Methodist Hospital in Houston Further Its Research Mission
7. Harris Methodist Fort Worth Hospital Using Bubbles to Help Babies Breathe
8. Novel PCT Method Unveiled by Pressure BioSciences, Inc. and Collaborators at the Harvard School of Public Health
9. Pulmo BioTech Announces Details of the Methodology for its Phase I Human Trials
10. Novavax Announces Proprietary Method to Create SARS Vaccine and Renewal of NIH Funding for SARS Vaccine Development
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- OrthoAccel ® Technologies, Inc. announces that the ... Effect of Vibration on Molar Distalization," a study that ... Jay Bowman , this prospective, peer-reviewed clinical study concluded ... ® speeds up molar distalization rates in the ... days to move the upper molars into a normal, ...
(Date:1/17/2017)... 2017   Tocagen Inc ., a clinical-stage, cancer-selective gene therapy ... president, research and pharmaceutical development at Tocagen, will present at ... Jan. 17-20 in Miami . ... ... for replicating viruses - what to do when and why Date ...
(Date:1/17/2017)... Jan. 17, 2017  EMD Serono, the biopharmaceutical business ... in the U.S. and Canada , ... joined the company as Senior Vice President and Head ... Smith will oversee the Fertility and Endocrinology businesses in ... launched its first product last year with Gidget™, a ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will demonstrate its ... Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention Center in ... the gold standard for high-definition, in-ear earphones. This classic earphone has been updated ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting ... Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted ... providers. , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New York’s ... care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment of ... according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD ...
(Date:1/17/2017)... ... ... Neil H. Greco Insurance Agency, a northern New Jersey firm that provides ... a charity drive to raise awareness of heart disease and promote habits that improve ... is responsible for 1 in every 4 deaths at the national level each year. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare ... blind clinical study for its dental gel that shows significant reduction in plaque levels ... containing triclosan. The study was conducted at the Beckman Laser Institute at UC Irvine ...
Breaking Medicine News(10 mins):